Lacticaseibacillus paracasei CCFM1224-derived lipids alleviate high-fat diet- induced obesity in mice via integrated metabolic modulation
Lipids derived from *Lacticaseibacillus paracasei* CCFM1224 postbiotics effectively alleviate high-fat diet-induced obesity in mice by modulating lipid metabolism, suppressing inflammation, and regulating satiety hormones, thereby reducing body weight, improving metabolic health, and remodeling hepatic lipid profiles.
Original paper licensed under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). This is an AI-generated explanation of a preprint that has not been peer-reviewed. It is not medical advice. Do not make health decisions based on this content. Read full disclaimer
Obesity is more than just a matter of weight; it is a complex disruption of the body's internal chemistry, where excess fat accumulates in places it should not, such as the liver, and triggers a state of low-grade inflammation that strains the entire system. For decades, scientists have looked to the trillions of microscopic organisms living in our guts for answers, hoping that the right bacteria could help reset this metabolic balance. While live bacteria, known as probiotics, have been studied extensively, a newer concept called postbiotics has emerged. These are not living creatures but rather the useful parts left behind when bacteria are inactivated—essentially the cellular components and byproducts that remain after the microbes are safely stopped. These non-living fragments offer a stable and safe way to deliver health benefits without the risks associated with introducing live organisms into the body. The question that has lingered, however, is exactly which part of these bacterial remains holds the power to fight obesity. Is it the protein shell, the genetic material, or perhaps the fats that make up the cell membrane?
Researchers at Jiangnan University in China set out to solve this puzzle by examining a specific strain of bacteria called Lacticaseibacillus paracasei CCFM1224, which they had previously found to be effective against weight gain. To find the active ingredient, they treated mice with a high-fat diet to induce obesity and then systematically tested different parts of the bacteria. First, they separated the bacteria from the liquid they grew in. They found that the liquid itself did nothing to stop the weight gain, but the inactivated bacterial cells did. This narrowed the search to the cells themselves. The team then broke the cells apart into their constituent parts: the outer wall, the proteins attached to that wall, the internal cell contents, and the lipids, or fats. When they fed these separate parts to the obese mice, only one component worked. The lipid fraction, the fats extracted from the bacterial cells, was the sole driver of the anti-obesity effect.
The results were striking. Mice that received the bacterial lipids gained significantly less weight than those in the untreated obese group, with their weight gain reduced by nearly 24 percent. Their livers, which had become heavy and fatty due to the poor diet, shrank by more than 37 percent, and their fat tissue around the organs decreased by over 21 percent. Beyond just losing weight, the treatment repaired the metabolic damage caused by the high-fat diet. The mice showed better control over their blood sugar, lower levels of harmful cholesterol, and a liver that was no longer inflamed. The researchers observed that the treatment reduced the levels of inflammatory signals in the liver, effectively calming the internal fire that often accompanies obesity.
The way this lipid fraction worked was through a coordinated effort across the body's systems. It acted like a switch for the body's hormones, increasing the levels of signals that tell the brain to feel full, such as GLP-1 and PYY, while lowering the levels of insulin and leptin, hormones that are often out of balance in obese individuals. Inside the fat tissue itself, the treatment changed how the cells behaved at a genetic level. It turned down the genes responsible for storing fat and turned up the genes that burn fat for energy and generate heat. This shift meant the fat cells were no longer just hoarding energy but were actively breaking it down.
To understand what was happening inside the liver at a molecular level, the scientists analyzed the specific fats present in the tissue. They found that the treatment caused a major reshuffling of the liver's chemical makeup. The amount of triglycerides, the type of fat that causes fatty liver disease, dropped significantly. At the same time, the levels of sphingomyelins, a type of fat that helps build and stabilize cell membranes, increased. This suggests that the bacterial lipids not only helped clear out the excess storage fat but also strengthened the structural integrity of the liver cells, protecting them from damage.
This study provides a clear map of how a specific postbiotic component can fight obesity. It confirms that the anti-obesity power of this particular bacteria comes entirely from its lipid fraction, not from its proteins or its fermentation byproducts. By targeting multiple pathways at once—reducing inflammation, adjusting hunger hormones, and reprogramming how fat cells store and burn energy—these bacterial fats offer a promising avenue for precision nutrition. The findings suggest that future strategies for managing weight and metabolic health could focus on these specific microbial lipids, offering a stable and effective tool to help the body regain its balance without relying on live bacteria.
Drowning in papers in your field?
Get daily digests of the most novel papers matching your research keywords — with technical summaries, in your language.